Treatment of Venous Malformation
- Conditions
- Venous Malformation
- Registration Number
- NCT05586919
- Lead Sponsor
- Al-Azhar University
- Brief Summary
Vascular malformations are birth defects that happen when different stages of angiogenesis shut down. 44 - 64% of all vascular malformations are venous malformations (VMs). Sclerotherapy is the first treatment line for VMs. It acts by getting rid of the vascular endothelial cells in the lesion. One of the most common and well researched sclerosing agents for VMs is polidocanol, which is a popular counterpart for concentrated ethanol.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
- Patients diagnosed with venous malformation of both genders and age above one year.
- Age below one year.
- Patients had any other vascular malformations.
- Indication for contrast material or Alcohol and polidocanol injection.
- Unfit for general anesthesia. 5) Pregnancy. 6) Skin infection, inflammation, and ulcers.
- Pulmonary embolism.
- Acute Ischemia, and acute DVT.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Disfigurement questionnaire 6 months post operative Disfigurementof the affected part may be unchanged, or decreased or disppeared, or relapsed
Heaviness questionnaire 6 months post operative Heaviness of the affected part may be unchanged, or decreased or disppeared, or relapsed
size of venous malformation 6 months post operative it assess the size of malformations after injection; which may be unchanged, or decreased or disppeared, or relapsed
Degree of satisfaction 6 months post operative It may be; Very satisfied, or satisfied, or not satisfied, or Dissatisfied.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Walied Khereba
🇪🇬Zagazig, Egypt
Walied Khereba🇪🇬Zagazig, Egypt